RTOG 9802: Good wines need aging

Journal of Clinical Oncology

Volumn 31, Issue 5, 2013, Pages 653-654

  Van Den Bent, Martin J ^a   Jaeckle, Kurt ^b   Baumert, Brigitta ^c   Wick, Wolfgang ^d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MAYO CLINIC   (United States)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LOMUSTINE; PROCARBAZINE; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; GLIOMA; HUMAN; LETTER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY, ADJUVANT; GLIOMA; HUMANS; SUPRATENTORIAL NEOPLASMS;

EID: 84875411169     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.46.6896     Document Type: Letter

References (8)

1. Shaw EG, Wang M, Coons SW, et al: Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: Initial results of RTOG 9802. J Clin Oncol 30: 3065-3070, 2012
2. Shaw EG, Wang M, Coons S, et al: Final report of Radiation Therapy Oncology Group (RTOG) protocol 9802: Radiation therapy (RT) versus RT - procarbazine, CCNU, and vincristine (PCV) chemotherapy for adult low-grade glioma (LGG). J Clin Oncol 26:90s, 2008 (suppl; abstr 2006)
3. van den Bent MJ, Carpentier AF, Brandes AA, et al: Adjuvant procarbazine, lomustine, and vincristine improves progression free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 24: 2715-2722, 2006 (Pubitemid 46630567)
4. Intergroup Radiation Therapy Oncology Group Trial 9402, Cairncross JG, Berkey B, et al: Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24: 2707-2714, 2006
5. van den Bent MJ, Dubbink HJ, Marie Y, et al: IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: A report of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Clin Cancer Res 16: 1597-1604, 2010
6. Coons SW, Johnson PC, Scheithauer BW, et al: Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79: 1381-1393, 1997 (Pubitemid 27143246)
7. van den Bent MJ: Interobserver variation of the histopathological diagnosis in clinical trials on glioma: A clinician's perspective. Acta Neuropathol 120:297- 304, 2010
8. Shaw EG, Berkey B, Coons SW, et al: Radiation Therapy and Oncology Group protocol 9802: Radiation therapy alone versus RT - PCV chemotherapy in adult low-grade glioma. Neuro Oncol 8: 489-490, 2006 (abstr RO-26)